# S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

> **NCT00003908** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 68 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00003908
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2004-06
- **Final completion:** 2007-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2013-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003908, "S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*